Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gallinger

Showing results (91-100 of 150) with videos related to

Pageof 15
Sort By:
Oncogene|October 11, 2001
Dysregulation of integrin-linked kinase (ILK) signaling in colonic polyposisA Marotta, C Tan, V Gray, et al.
Chronic Diseases in Canada|September 29, 2000
Ontario familial colon cancer registry: methods and first-year response ratesM Cotterchio, G McKeown-Eyssen, H Sutherland, et al.
Human Pathology|April 20, 1999
Monoclonal antibody Adnab-9 defines a preneoplastic marker in epithelium at risk for adenocarcinoma of the small intestineM Tobi, V Kaila, N Hassan, et al.
Cancer Research|July 23, 1999
Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathwayL Mirabelli-Primdahl, R Gryfe, H Kim, et al.
British Journal of Cancer|May 19, 2000
Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinomaG Liu, P Ghadirian, D Vesprini, et al.
Cancer Research|August 17, 2001
Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitorG Lal, C Ash, K Hay, et al.
Clinical Genetics|September 26, 2007
Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioningM J Esplen, L Madlensky, M Aronson, et al.
The American Journal of Pathology|January 23, 1999
Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological, and molecular genetics studyC Soravia, S L Sugg, T Berk, et al.
Cardiovascular and Interventional Radiology|January 4, 2007
Percutaneous ethanol injection of unresectable medium-to-large-sized hepatomas using a multipronged needle: efficacy and safetyC S Ho, J R Kachura, S Gallinger, et al.
Nuclear Medicine and Biology|January 1, 1993
Compartmental analysis of the pharmacokinetics of radioiodinated monoclonal antibody B72.3 in colon cancer patientsR M Reilly, J Kirsh, S Gallinger, et al.
Pageof 15

Showing results (91-100 of 150) with videos related to

Sort By:
Pageof 15
Oncogene|October 11, 2001
Dysregulation of integrin-linked kinase (ILK) signaling in colonic polyposisA Marotta, C Tan, V Gray, et al.
Chronic Diseases in Canada|September 29, 2000
Ontario familial colon cancer registry: methods and first-year response ratesM Cotterchio, G McKeown-Eyssen, H Sutherland, et al.
Human Pathology|April 20, 1999
Monoclonal antibody Adnab-9 defines a preneoplastic marker in epithelium at risk for adenocarcinoma of the small intestineM Tobi, V Kaila, N Hassan, et al.
Cancer Research|July 23, 1999
Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathwayL Mirabelli-Primdahl, R Gryfe, H Kim, et al.
British Journal of Cancer|May 19, 2000
Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinomaG Liu, P Ghadirian, D Vesprini, et al.
Cancer Research|August 17, 2001
Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitorG Lal, C Ash, K Hay, et al.
Clinical Genetics|September 26, 2007
Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioningM J Esplen, L Madlensky, M Aronson, et al.
The American Journal of Pathology|January 23, 1999
Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological, and molecular genetics studyC Soravia, S L Sugg, T Berk, et al.
Cardiovascular and Interventional Radiology|January 4, 2007
Percutaneous ethanol injection of unresectable medium-to-large-sized hepatomas using a multipronged needle: efficacy and safetyC S Ho, J R Kachura, S Gallinger, et al.
Nuclear Medicine and Biology|January 1, 1993
Compartmental analysis of the pharmacokinetics of radioiodinated monoclonal antibody B72.3 in colon cancer patientsR M Reilly, J Kirsh, S Gallinger, et al.
Pageof 15